Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Faculty Publications Book Chapter Faculty Publications- Book Chapter Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Creator An entity primarily responsible for making the resource Shakya, Richa; Srivastava, Shivam; Paul Richards, M.; Agrawal, Ankur; Saharan, Renu; Bhise, Manish R.; Suresh, Venkata; Anjali, P.K. Title A name given to the resource Ethical considerations in nanomedicine research involving women Date A point or period of time associated with an event in the lifecycle of the resource 01-01-2025 Source A related resource from which the described resource is derived Nanomedicine Advancements and Intersectional Perspectives for Women's Health;pp.237-263 Identifier An unambiguous reference to the resource within a given context <a href="https://doi.org/10.1016/B978-0-443-33056-8.00005-1" target="_blank" rel="noreferrer noopener">https://doi.org/10.1016/B978-0-443-33056-8.00005-1</a> <br /><br /><a href="https://www.scopus.com/pages/publications/105026848032?origin=resultslist" target="_blank" rel="noreferrer noopener">https://www.scopus.com/pages/publications/105026848032?origin=resultslist</a> Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Shakya R., Department of Pharmacy, Faculty of Pharmaceutical Sciences, Rama University, Uttar Pradesh, Kanpur, India; Srivastava S., Truba College of Pharmacy, Madhya Pradesh, Bhopal, India; Paul Richards M., Aditya Bangalore Institute of Pharmacy Education and Research, Affiliated to Rguhs, Karnataka, Bangalore, India; Agrawal A., Department of Pharmacy, Jai Institute of Pharmaceutical Sciences and Research, Madhya Pradesh, Gwalior, India; Saharan R., Department of Pharmacy, M. M. College of Pharmacy, MMDU, Haryana, Ambala, India; Bhise M.R., Department of Pharmaceutics, SGSPS, Institute of Pharmacy, Affiliated to Sant Gadge Baba Amravati University, Maharashtra, Amravati, India; Suresh V., Department of Pharmacy, Vathsalya College of Pharmacy, Telangana, Bhuvanagiri, India; Anjali P.K., Department of Economics, CHRIST (Deemed to be University), Karnataka, Bangalore, India Description An account of the resource This chapter elaborates social impact and perspectives of advanced technologies as well as critically discuss the ethical issues of womens participation in nano-medicine research. It starts by addressing the issue that women have been under sampled in clinical research but it is moral to take their samples farther into research most notably with certain special health conditions and unique reactions to drug treatments that are likely to be unique to women. One of the most emphasized concepts is informed consent, for the purpose of precisions and clarity in explaining its purpose and usefulness, as well as the probable consequences in the form of some narrowly speculative treatments with particular relevance to certain probabilities remaining beyond the range of perception on the female body after some or other nano-scale procedures. The chapter also talks about the ethical implications in the present strategies to increase the efficacy and safety for women only therapies like nanomedicine; the author urges for stringent preclinical and clinical guidelines which should have examined the following gender variations. It also examines the regulation with guidance and suggests contingency structures that are employed in the management of the ethical use of nanomedicine in women health care. Therefore this chapter tries to develop ethics together with science, incorporate these met ethical considerations into methods and guidelines in research, to contribute to enhancement of beneficial impact of the nanomedicine for womens rights and well-being. 2026 Elsevier Inc. All rights reserved.. Subject The topic of the resource clinical trials; ethical considerations; gender; Nanomedicine; women Publisher An entity responsible for making the resource available Elsevier Relation A related resource ISBN: 978-044333056-8; 978-044333057-5; Language A language of the resource English Type The nature or genre of the resource Book chapter Rights Information about rights held in and over the resource Restricted Access; Hardcopy may be available in the library Format The file format, physical medium, or dimensions of the resource online